news

Bigler Named Northwind President/COO

APRIL 2020 – Northwind Pharmaceuticals is excited to announce the promotion of Elizabeth “Betsy” Bigler to President/COO. Bigler joined Northwind in 2017 after 10 years of progressive leadership experience in local health systems. A 2008 graduate from the Purdue School of Nursing, Bigler obtained her Master’s degree from the University of Indianapolis in 2013 and her Six Sigma Blackbelt Certification in 2016. Betsy has led Northwind operations through rapid growth during the last 30 months and assumes broader leadership responsibilities across all aspects of the enterprise.

“Betsy has been incredibly effective at managing our operations through rapid growth,” said Phillip Berry, CEO. “Her strong leadership, ability to attract great talent, consultative approach, and broad clinical/operational capabilities have made her a tremendous asset to Northwind and our clients. Today’s announcement reflects Betsy’s continuing contributions.”

From Betsy Bigler, President/COO, “I am excited for my next chapter at Northwind. We are ideally positioned to make a difference for our patients and clients across the country while creating jobs and positive impact here in Indianapolis. Challenges like COVID-19 present tremendous opportunities for us to innovate for those who depend on us. I see great things ahead!”

Northwind provides pharmaceutical repackaging, fulfillment, and support services to patients, medical providers, and employer groups nationally. Through its innovative Rx@Work™, Rx@Home™, and RxAdministration™ solutions, Northwind enables medical providers to get prescription drugs to their patients when and where needed while decreasing drug costs for self-funded employers.

Schedule a free claims analysis now.

Let’s Talk now

New Drugs to Market – October Update

Phillip Berry | Oct 25th, 2024
The Food and Drug Administration (FDA) approved three novel drug therapies in October. One of those therapies,  Hympavzi (marstacimab-hncq), is a medication indicated for the treatment of patients with Hemophilia A and Hemophilia B. Hympavzi utilizes a new pathway to help reduce the risk of bleeding episodes in patients with Hemophilia, a disease that impacts … more »

continue reading

Letter From a Pharmacist – On Pharmacy Closures

Phillip Berry | Oct 25th, 2024
Pharmacists have a time-honored role as an integral contributor to the delivery of health care. From the earliest apothecaries to the retail stores of today, community pharmacists have provided guidance about health, wellness and medication therapy. Their expertise ranges from preventive care to the most advanced medications used in the treatment of complex disease.  Despite … more »

continue reading

Stewardship and the Beauty of Health Benefits

Phillip Berry | Oct 25th, 2024
The Beauty of Making a Difference Beauty in health benefits? What does that even mean? Think back on your experience as an HR/benefits professional. What are the peak moments? Most would agree that the high points are moments when they see their work directly impacting an employee or plan member. A time when the health … more »

continue reading